Search

Kimiko Della Croce

from Tucson, AZ
Age ~62
Get Report
Also known as:
Kimiko D Croce, Kimiko Cp Della, Kimiko Della Dellacroce, Kimiko Tachibana, Kimik Tachibana
Related to:
Hannah M Butler, 25Gloria Della Croce, 98Angela D Croce, 32Anthony Della Croce, 58
Connected to:
Alex A Croce, 70Claudette F Croce, 66Eliana S Croce, 29Erika L Croce, 35Giuseppe T Croce, 46Jennifer Croce, 54Kristina O Croce, 76Lynn Croce, 75Mimma A Croce, 35Nicola Croce, 71

Kimiko Croce Phones & Addresses

  • Tucson, AZ

Work

Company: The university of arizona Jan 1991 Position: Research staff

Education

Degree: Bachelors School / High School: University of Arizona 1987 to 1990

Resumes

Resumes

Kimiko Croce Photo 1

Research Staff

View page
Location:
Tucson, AZ
Work:
The University of Arizona
Research Staff
Education:
University of Arizona 1987 - 1990
Bachelors

Publications

Us Patents

Protein Kinase Inhibitors

View page
US Patent:
20050239793, Oct 27, 2005
Filed:
Mar 29, 2005
Appl. No.:
11/092809
Inventors:
Laurence Hurley - Tucson AZ, US
Daruka Mahadevan - Tucson AZ, US
Haiyong Han - Tucson AZ, US
David Bearss - Cedar Hills UT, US
Hariprasad Vankayalapati - Salt Lake City UT, US
Sridevi Bashyam - Tucson AZ, US
Ruben Munoz - Tucson AZ, US
Steven Warner - Tucson AZ, US
Kimiko Della Croce - Tucson AZ, US
Daniel Von Hoff - Scottsdale AZ, US
Cory Grand - Salt Lake City UT, US
Assignee:
Arizona Board of Regents on behalf of The University of Arizona - Tucson AZ
Montigen Pharmaceuticals, Inc. - Salt Lake City UT
International Classification:
A61K031/519
C07D487/14
US Classification:
514252160, 544250000
Abstract:
Protein kinase inhibitors are disclosed having utility in the treatment of protein kinase-mediated diseases and conditions, such as cancer. The compounds of this invention have the following structure: including steroisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein A is a ring moiety selected from: and wherein R1, R2, R3, X, Z, L1, Cycl1, L2 and Cycl2 are as defined herein. Also disclosed are compositions containing a compound of this invention, as well as methods relating to the use thereof.

Protein Kinase Inhibitors

View page
US Patent:
20050239794, Oct 27, 2005
Filed:
Mar 29, 2005
Appl. No.:
11/092863
Inventors:
Laurence Hurley - Tucson AZ, US
Daruka Mahadevan - Tucson AZ, US
Haiyong Han - Tucson AZ, US
David Bearss - Cedar Hills UT, US
Hariprasad Vankayalapati - Salt Lake City UT, US
Sridevi Bashyam - Tucson AZ, US
Ruben Munoz - Tucson AZ, US
Steven Warner - Tucson AZ, US
Kimiko Della Croce - Tucson AZ, US
Daniel Von Hoff - Scottsdale AZ, US
Cory Grand - Salt Lake City UT, US
Assignee:
Arizona Board of regents on behalf of the University of Arizona - Tucson AZ
Montigen Pharmaceuticals, Inc. - Salt Lake City UT
International Classification:
A61K031/519
C07D487/14
US Classification:
514252160, 544250000
Abstract:
Protein kinase inhibitors are disclosed having utility in the treatment of protein kinase-mediated diseases and conditions, such as cancer. The compounds of this invention have the following structure: including steroisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein A is a ring moiety selected from: and wherein R1, R2, R3, X, Z, L1, Cycl1, L2 and Cycl2 are as defined herein. Also disclosed are compositions containing a compound of this invention, as well as methods relating to the use thereof.

Protein Kinase Inhibitors

View page
US Patent:
20050277658, Dec 15, 2005
Filed:
Mar 29, 2005
Appl. No.:
11/092168
Inventors:
Laurence Hurley - Tucson AZ, US
Daruka Mahadevan - Tucson AZ, US
Haiyong Han - Tucson AZ, US
David Bearss - Cedar Hills UT, US
Hariprasad Vankayalapati - Salt Lake City UT, US
Sridevi Bashyam - Tucson AZ, US
Ruben Munoz - Tucson AZ, US
Steven Warner - Tucson AZ, US
Kimiko Della Croce - Tucson AZ, US
Daniel Von Hoff - Scottsdale AZ, US
Cory Grand - Salt Lake City UT, US
Assignee:
Arizona Board of Regents on behalf of The University of Arizona - Tucson AZ
Montigen Pharmaceuticals, Inc. - Salt Lake City UT
International Classification:
A61K031/519
C07D487/02
US Classification:
514267000, 544250000
Abstract:
Protein kinase inhibitors are disclosed having utility in the treatment of protein kinase-mediated diseases and conditions, such as cancer. The compounds of this invention have the following structure: including steroisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein A is a ring moiety selected from: and wherein R1, R2, R3, X, Z, L1, Cycl1, L2 and Cycl2 are as defined herein. Also disclosed are compositions containing a compound of this invention, as well as methods relating to the use thereof.

Protein Kinase Inhibitors

View page
US Patent:
20080051414, Feb 28, 2008
Filed:
Mar 1, 2007
Appl. No.:
11/680921
Inventors:
Laurence Hurley - Tucson AZ, US
Daruka Mahadevan - Tucson AZ, US
Haiyong Han - Chandler AZ, US
David Bearss - Cedar Hills UT, US
Hariprasad Vankayalapati - Draper UT, US
Sridevi Bashyam - Bangalore, IN
Ruben Munoz - Chandler AZ, US
Steven Warner - Mesa AZ, US
Kimiko Della Croce - Tucson AZ, US
Daniel Von Hoff - Scottsdale AZ, US
Cory Grand - Salt Lake City UT, US
James Welsh - Oro Valley AZ, US
Assignee:
Arizona Board of Regents on Behalf of The University of Arizona - Tucson AZ
SuperGen,Inc - Dublin CA
International Classification:
A61K 31/496
A61P 35/00
A61P 43/00
C07D 241/04
C07D 401/14
C07D 403/02
C07D 471/04
US Classification:
514252170, 514252120, 514252140, 514252160, 544250000, 544284000, 544295000, 544358000
Abstract:
Protein kinase inhibitors are disclosed having utility in the treatment of protein kinase-mediated diseases and conditions, such as cancer. The compounds of this invention have the following structure: including steroisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein A is a ring moiety selected from: and wherein R, R, R, X, Z, L, Cycl, Land Cyclare as defined herein. Also disclosed are compositions containing a compound of this invention, as well as methods relating to the use thereof.

Protein Kinase Inhibitors

View page
US Patent:
20090099165, Apr 16, 2009
Filed:
Apr 13, 2007
Appl. No.:
11/735344
Inventors:
Laurence H. Hurley - Tucson AZ, US
Daruka Mahadevan - Tucson AZ, US
Haiyong Han - Chandler AZ, US
David J. Bearss - Cedar Hills UT, US
Hariprasad Vankayalapati - Draper UT, US
Sridevi Bashyam - Bangalore, IN
Ruben M. Munoz - Chandler AZ, US
Steven L. Warner - Sandy UT, US
Kimiko Della Croce - Tucson AZ, US
Daniel D. Von Hoff - Scottsdale AZ, US
Cory L. Grand - Dublin CA, US
James Welsh - Oro Valley AZ, US
Assignee:
Arizona Board of Regents on Behalf of The University of Arizona - Tucson AZ
Montigen Pharmaceuticals, Inc. - Salt Lake City UT
International Classification:
A61K 31/5377
C07D 487/04
A61K 31/519
US Classification:
5142328, 544250, 51425216, 544115, 514267
Abstract:
Protein kinase inhibitors are disclosed having utility in the treatment of protein kinase-mediated diseases and conditions, such as cancer. The compounds of this invention have the following structure:including steroisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein A is a ring moiety selected from:and wherein R1, R2, R3, X, Z, L1, Cycl1, L2 and Cycl2 are as defined herein. Also disclosed are compositions containing a compound of this invention, as well as methods relating to the use thereof.

Protein Kinase Inhibitors

View page
US Patent:
20090143399, Jun 4, 2009
Filed:
Aug 20, 2007
Appl. No.:
11/841574
Inventors:
Laurence H. Hurley - Tucson AZ, US
Daruka Mahadevan - Tucson AZ, US
Haiyong Han - Chandler AZ, US
David J. Bearss - Cedar Hills UT, US
Hariprasad Vankayalapati - Draper UT, US
Sridevi Bashyam - Bangalore, IN
Ruben M. Munoz - Chandler AZ, US
Steven L. Warner - Mesa AZ, US
Kimiko Della Croce - Tucson AZ, US
Daniel D. Von Hoff - Scottsdale AZ, US
Cory L. Grand - Salt Lake City UT, US
James Welsh - Oro Valley AZ, US
Assignee:
ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA - TUCSON AZ
SUPERGEN, INC. - DUBLIN CA
International Classification:
A61K 31/496
C07D 487/04
C07D 495/14
C07D 491/048
A61P 35/04
US Classification:
51425216, 544250
Abstract:
Protein kinase inhibitors are disclosed having utility in the treatment of protein kinase-mediated diseases and conditions, such as cancer. The compounds of this invention have the following structure:including steroisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein A is a ring moiety selected from:and wherein R1, R2, R3, X, Z, L1, Cycl1, L2 and Cycl2 are as defined herein. Also disclosed are compositions containing a compound of this invention, as well as methods relating to the use thereof.

Protein Kinase Inhibitors

View page
US Patent:
20110212929, Sep 1, 2011
Filed:
Mar 18, 2011
Appl. No.:
13/051790
Inventors:
Laurence H. Hurley - Tucson AZ, US
Daruka Mahadevan - Tucson AZ, US
Haiyong Han - Chandler AZ, US
David J. Bearss - Cedar Hills UT, US
Hariprasad Vankayalapati - Draper UT, US
Sridevi Bashyam - Bangalore, IN
Ruben M. Munoz - Chandler AZ, US
Steven L. Warner - Sandy UT, US
Kimiko Della Croce - Tucson AZ, US
Daniel D. Von Hoff - Scottsdale AZ, US
Cory L. Grand - Dublin CA, US
James Welsh - Oro Valley AZ, US
International Classification:
A61K 31/635
C07D 487/04
A61K 31/496
C07D 471/14
A61K 31/519
C07D 413/14
A61K 31/5377
A61P 35/00
US Classification:
514157, 544250, 51425216, 514267, 544115, 5142328
Abstract:
Protein kinase inhibitors are disclosed having utility in the treatment of protein kinase-mediated diseases and conditions, such as cancer. The compounds of this invention have the following structure:including steroisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein A is a ring moiety selected from:and wherein R1, R2, R3, X, Z, L1, Cycl1, L2 and Cycl2 are as defined herein. Also disclosed are compositions containing a compound of this invention, as well as methods relating to the use thereof.

Protein Kinase Inhibitors

View page
US Patent:
20050227992, Oct 13, 2005
Filed:
Oct 14, 2004
Appl. No.:
10/965313
Inventors:
Laurence Hurley - Tucson AZ, US
Daruka Mahadevan - Tucson AZ, US
Haiyong Han - Tucson AZ, US
David Bearss - Cedar Hills UT, US
Hariprasad Vankayalapati - Salt Lake City UT, US
Sridevi Bashyam - Tucson AZ, US
Ruben Munoz - Tucson AZ, US
Steven Warner - Tucson AZ, US
Kimiko Della Croce - Tucson AZ, US
Daniel Von Hoff - Scottsdale AZ, US
Cory Grand - Salt Lake City UT, US
Assignee:
Arizona Board of Regents on behalf of The University of Arizona - Tucson AZ
Montigen Pharmaceuticals, Inc. - Salt Lake City UT
International Classification:
A61K031/517
C07D487/02
US Classification:
514252160, 544250000
Abstract:
Protein kinase inhibitors are disclosed having utility in the treatment of protein kinase-mediated diseases and conditions, such as cancer. The compounds of this invention have the following structure: including steroisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein A is a ring moiety selected from: and wherein R1, R2, R3, X, Z, L1, Cycl1, L2 and Cycl2 are as defined herein. Also disclosed are compositions containing a compound of this invention, as well as methods relating to the use thereof.
Control profile
Kimiko Della Croce from Tucson, AZ, age ~62 Get Report